Vexev, announced the highly successful results of the CANSCAN Trial (NCT06691672), providing evidence that the VxWave ...

Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading ...

The VxWave system’s potential ability to standardize examinations would allow dialysis clinics to better determine subgroups who may be at a disadvantage for vascular access creation, ultimately ...

Vexev and U.S. Renal Care today announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system.

Modern obstetric advances have improved labor management with pain medication integration, yet gynecologic pain management ...

The brain is never completely at rest. Even without external input, it produces spontaneous neural activity that creates synchronized fluctuations across different regions - a process known as ...

Italian biomedical company Esaote has partnered with Schiller Americas to expand access to its ultrasound systems across U.S. cardiology practices. Under the agreement, Schiller will offer Esaote’s ...

Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...

Following the group restructuring, Onward Therapeutics, Inc. serves as the global headquarters and holding company in Taiwan.The existing Swiss and French subsidiaries maintain fully operational, ...

Top 3 industry verticals fueling Singapore's cross-border growth are gaming, beauty, and fashion, which generated over US$1.6B1 in transaction value.Beyond the U.S., Singapore businesses are capturing ...

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...

Has organ imaging using ultrasound arrived at the same level as cross-sectional imaging? At the annual conference of the ...